Saliva Collection & Diagnostics Market (By Saliva Type; By Application; By End-use: Dentistry, Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Saliva Collection & Diagnostics Market 

5.1. COVID-19 Landscape: Saliva Collection & Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Saliva Collection & Diagnostics Market, By Saliva Type

8.1. Saliva Collection & Diagnostics Market, by Saliva Type, 2022-2030

8.1.1 Whole Saliva

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Glandular Saliva

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Other

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Saliva Collection & Diagnostics Market, By Application

9.1. Saliva Collection & Diagnostics Market, by Application, 2022-2030

9.1.1. Disease Diagnostics

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Forensic applications

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Research

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Saliva Collection & Diagnostics Market, By End use 

10.1. Saliva Collection & Diagnostics Market, by End use, 2022-2030

10.1.1. Dentistry

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Diagnostic laboratories

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Pharmaceutical & Biotechnology companies

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Research Institutes

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Saliva Collection & Diagnostics Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.1.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.3. Market Revenue and Forecast, by End use (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.4.3. Market Revenue and Forecast, by End use (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.1.5.3. Market Revenue and Forecast, by End use (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.2.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.3. Market Revenue and Forecast, by End use (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.4.3. Market Revenue and Forecast, by End use (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.5.3. Market Revenue and Forecast, by End use (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.6.3. Market Revenue and Forecast, by End use (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.2.7.3. Market Revenue and Forecast, by End use (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.3.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.3. Market Revenue and Forecast, by End use (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.4.3. Market Revenue and Forecast, by End use (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.5.3. Market Revenue and Forecast, by End use (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.6.3. Market Revenue and Forecast, by End use (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.3.7.3. Market Revenue and Forecast, by End use (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.3. Market Revenue and Forecast, by End use (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.4.3. Market Revenue and Forecast, by End use (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.5.3. Market Revenue and Forecast, by End use (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.6.3. Market Revenue and Forecast, by End use (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

11.4.7.3. Market Revenue and Forecast, by End use (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.3. Market Revenue and Forecast, by End use (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.4.3. Market Revenue and Forecast, by End use (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Saliva Type (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

11.5.5.3. Market Revenue and Forecast, by End use (2017-2030)

Chapter 12. Company Profiles

12.1. OraSure Technologies

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Draeger

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Securetec Detektions-Systeme

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Oranoxis

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Lin-Zhi International

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Oasis Diagnostics

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Cell Projects

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Prometheus bio

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Quest Diagnostics

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Abbott Laboratories

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Report Details

  • Report Code:39704
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:September 2022
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers